PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 123 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,547,000 | -12.9% | 260,046 | +7.8% | 0.10% | -11.7% |
| Q3 2017 | $1,776,000 | +36.0% | 241,276 | +25.4% | 0.11% | +22.0% |
| Q2 2017 | $1,306,000 | +22.5% | 192,413 | +70.4% | 0.09% | +24.7% |
| Q1 2017 | $1,066,000 | +85.4% | 112,913 | +69.7% | 0.07% | +82.5% |
| Q4 2016 | $575,000 | -51.8% | 66,548 | -64.7% | 0.04% | -54.0% |
| Q3 2016 | $1,192,000 | +46.6% | 188,299 | -2.3% | 0.09% | +42.6% |
| Q2 2016 | $813,000 | +19.7% | 192,675 | +23.8% | 0.06% | +27.1% |
| Q1 2016 | $679,000 | -13.5% | 155,627 | +21.6% | 0.05% | -9.4% |
| Q4 2015 | $785,000 | -8.0% | 128,017 | -14.2% | 0.05% | -11.7% |
| Q3 2015 | $853,000 | -30.1% | 149,153 | -8.9% | 0.06% | -11.8% |
| Q2 2015 | $1,221,000 | – | 163,660 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|